Denmark turns away at least 100 at German border over new Covid-19 rules

Over 100 people have been refused entry to Denmark in recent days due to rules requiring documentation of a negative Covid-19 test.

Denmark turns away at least 100 at German border over new Covid-19 rules
Photo: Frank Cilius/Ritzau Scanpix

The refusals occurred at the two harbours of Rødby and Gedser, Ritzau reports. They do therefore not take into account overland borders in South Jutland.

Acting police senior inspector Peter Compen confirmed the figure to public service broadcaster DR.

Travellers were denied entry to Denmark due to new rules which came into force on Saturday January 9th. Those rules require people travelling into the country to produce a negative Covid-19 test and have a valid reason to travel.

READ ALSO: Denmark bans flights without negative Covid-19 tests

Compen told DR that most people were disappointed about being denied entry but had generally taken the situation well.

He added that he expects most to return after taking a new coronavirus test.

Foreign nationals who are not resident in Denmark must have documentation of a negative Covid-19 test taken within the last 24 hours at entry to Denmark, according to the current rules.

For air travel, the negative test must be taken within 24 hours of boarding the incoming flight.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.


Covid-19 medicine Paxlovid now available in Denmark

Denmark has received its first supply of Paxlovid, an antiviral treatment for Covid-19.

Covid-19 medicine Paxlovid now available in Denmark

A first stock of Paxlovid, a tablet which can be described by doctors to combat Covid-19 symptoms, has been delivered to Denmark, health authorities confirmed in a statement.

“The first delivery has arrived today and the rest will be delivered continuously during the coming period,” the Danish Health Authority said.

Denmark has purchased 40,000 treatment courses of the medicine.

Doctors decide when to prescribe the medicine, which is suitable for adults infected with Covid-19 who are at risk of serious illness with Covid-19. It is taken over a course of five days when symptoms are still mild.

“Treatment with Paxlovid is for the patients who are at greatest risk of serious illness with Covid-19 and the treatment will be an important part of the future management of Covid-19,” the Health Authority said in the statement.

The arrival of a medicine for Covid-19 does not signal the end of vaccination which remains “the most effective measure to prevent serious illness and death,” it said.

Denmark has purchased the Paxlovid supply through a deal with pharmaceutical company Pfizer.

The infectious disease control agency State Serum Institute (SSI) has 2.2 million Covid-19 vaccines which have been in storage for so long that they are no longer usable, news wire Ritzau earlier reported.

The vaccines were purchased when Denmark was acquiring as many as possible during the pandemic but because they are not effective against newer variants of the coronavirus, they can no longer be used.

Another 3.6 million doses in storage at SSI can only be used for the initial two doses for as-yet unvaccinated people – who are now limited in number given Denmark’s high vaccine uptake. This means they are unusable in the current booster programme.

The cost of the 5.8 million vaccines is estimated at between 116 and 783 million kroner.